The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to a trochanteric nailing system.
The nailing system, per the 510(k) summary document, is intended for “use in fracture fixation in the femur in adults with osteopenia or osteoporosis.” According to the 510(k) summary document, the nailing system is indicated for use in the following:
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
